2024-10-31 03:23:02
RedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue
Corporate/ 2023-07-23
RedHill Biopharma's Phase 2/3 COVID...

Independent Data Safety Monitoring Board unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib i...

Copan, putting Covid-19 challenges behind and setting up for the post-pandemic scenario
Health/ 2023-07-22
Copan, putting Covid-19 challenges behin...

BRESCIA,Italy,April 10,2021-- With an email to the main distributors,Copan group\'s CEO describes how the ramp-up of Covid-19-related produc...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release